Filters: Format: "application/pdf"
151 - 175 of 16,034
Number of results to display per page
TitleDateTypeSetname
151 Select Patients with High-Risk Idiopathic Intracranial Hypertension May Be Managed with Medical Therapy Alone2023-03-14Textehsl_novel_nam
152 Pseudotumor Cerebri Patients Can Be Managed Remotely by an OCT-Based Telemedicine Model2023-03-14Textehsl_novel_nam
153 The Impact of The COVID-19 Pandemic on Patients with Established Idiopathic Intracranial Hypertension2023-03-14Textehsl_novel_nam
154 Predictors of Mortality and Visual Morbidity in Cavernous Sinus Thrombosis2023-03-14Textehsl_novel_nam
155 Dysmotility in Thyroid Eye Disease: Volumetric and Density Analysis2023-03-14Textehsl_novel_nam
156 A First-in-Human Phase 1 Randomized, Singleascending Dose Study of VB421 (lonigutamab), an Anti-IGF-1R Monoclonal Antibody, in Healthy Volunteers2023-03-14Textehsl_novel_nam
157 Cobalt Toxicity Induces Optic Neuritis in Mice2023-03-14Textehsl_novel_nam
158 Quantification of Saccadic Fatigability for a Diagnosis of Myasthenia Gravis2023-03-14Textehsl_novel_nam
159 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor in Development for Thyroid Eye Disease (TED), Binds to a Distinct Epitope from Teprotumumab2023-03-14Textehsl_novel_nam
160 Neurologic Manifestations Associated with Endogenous Endophthalmitis2023-03-14Textehsl_novel_nam
161 Detecting Neurodegeneration on Optic Nerve and Cornea in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder2023-03-14Textehsl_novel_nam
162 THRIVE: A Phase 3 Trial of VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED)2023-03-14Textehsl_novel_nam
163 The Role of Teprotumumab in the Treatment of Diplopia Due to Thyroid Eye Disease2023-03-14Textehsl_novel_nam
164 VRDN-002, a Next-Generation Novel Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Results of a Phase 1 Trial2023-03-14Textehsl_novel_nam
165 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor in Development for Thyroid Eye Disease (TED): Interim Phase 1/2 Pharmacodynamic Results2023-03-14Textehsl_novel_nam
166 Optic Nerve Optical Coherence Tomography Correlates with Brain Swelling and Intracranial Pressure in Cerebral Malaria2023-03-14Textehsl_novel_nam
167 Optical Computed Tomography in Pediatric Patients with MOG-Associated Optic Neuritis2023-03-14Textehsl_novel_nam
168 Visual Outcomes and Etiologies of Recurrent Optic Neuritis in Children2023-03-14Textehsl_novel_nam
169 Development of a Portable, Automated Evaluation of Ocular Misalignment2023-03-14Textehsl_novel_nam
170 A Neuro-Ophthalmic Presentation of Allergic Fungal Sinusitis2023-03-14Textehsl_novel_nam
171 Neuro-ophthalmology Emergency Department and Inpatient Consultations at a Tertiary Care Center2023-03-14Textehsl_novel_nam
172 Giant Cell Arteritis Presenting with Light-Induced Amaurosis and Central Retinal Artery Occlusion2023-03-14Textehsl_novel_nam
173 Miller-Fisher Syndrome in Pregnancy: Case Report and Literature Review2023-03-14Textehsl_novel_nam
174 Visual Outcome Following Plasma Exchange for Optic Neuritis2023-03-14Textehsl_novel_nam
175 "Papilledema" Neuro-Ophthalmology Consultations from the Hospital: A Prospective Study2023-03-14Textehsl_novel_nam
151 - 175 of 16,034